Jamjoom Pharma Award - 2020

Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market with its Expanded Portfolio and Geographic Presence

Jamjoom Pharmaceuticals is dedicated to being a center of excellence in healthcare and providing high-quality, safe, and effective products to meet the regional need.

JEDDAH, Saudi Arabia, Aug. 19, 2020 /PRNewswire/ -- Based on its recent analysis of the KSA emerging generic pharmaceuticals market, Frost & Sullivan recognizes Saudi Arabia-headquartered Jamjoom Pharmaceuticals with the 2020 KSA Company of the Year Award for its operational excellence and expanded product portfolio and footprint. The company leads the KSA market by adopting sustainable business models and clear growth strategies. Implementing best practices, such as the corporate governance and setting up their own R&D center, recruiting qualified staff, strictly adhering to regulatory systems, and ensuring scalability, the company has established itself as the pharma partner of choice in the KSA...

Read more..

Despite a particularly challenging 2019, Jamjoom Pharmaceuticals recorded 4% year-on-year growth and maintained

Its position as one of the top-ranked pharma companies in the KSA,” said Dr. Suhasini, Associate Director – Transformational Health. “Right from the start, it focused on building a world-class manufacturing facility. Its building design, layout, selection, and installation of equipment; plant validation; and other technical processes met the most stringent international industry standards. Owing to its strategic diversification of specialty product lines and accelerating growth in export markets, Jamjoom Pharmaceuticals has been able to expand its manufacturing facilities and grow organically...

Read more..